Eastman Chemical (EMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
EMN benefits from its innovation-driven growth strategy and cost-management actions amid demand headwinds in certain markets.
Evercore ISI took over coverage of Eastman Chemical with an In Line rating and $118 price target as well as 10 other chemical names. Dissonance between sputtering industrial demand into year-end and prospects for a "less bad" 2025 has "muddled the forward outlook for chemicals investors" and the firm's sense is further EBITDA and EPS cuts coming to Q1 and FY25 "are needed to clear the deck," the analyst says. However, Evercore suspects the stocks "move sharply higher with signs of improving demand, so begin to position accordingly," the analyst added.
This dividend increase reflects the board's confidence in EMN's steady earnings performance and strong cash flow generation.
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
The investment will enhance EMN's supply capacity for Saflex PVB products in the Automotive Premiums sector.
Eastman Chemical Company (NYSE:EMN ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Greg Riddle - IR Mark Costa - Board Chair and CEO William McLain - EVP and CFO Conference Call Participants David Begleiter - Deutsche Bank Patrick Cunningham - Citigroup Duffy Fischer - Goldman Sachs Frank Mitsch - Fermium Research Vincent Andrews - Morgan Stanley Michael Leithead - Barclays Josh Spector - UBS Jeff Zekauskas - JPMorgan Aleksey Yefremov - KeyCorp Mike Sison - Wells Fargo Kevin McCarthy - Vertical Research Partners John Roberts - Mizuho Laurence Alexander - Jefferies Salvator Tiano - Bank of America Operator Good day, everyone, and welcome to the Third Quarter 2024 Eastman Conference Call. Today's conference is being recorded.
EMN sees higher sales volume in Q3 due to the end of customer inventory de-stocking across most major end markets.
Although the revenue and EPS for Eastman Chemical (EMN) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Eastman Chemical (EMN) came out with quarterly earnings of $2.26 per share, beating the Zacks Consensus Estimate of $2.13 per share. This compares to earnings of $1.47 per share a year ago.
Beyond analysts' top -and-bottom-line estimates for Eastman Chemical (EMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.